Facilitation of pain in the human spinal cord by nocebo treatment

Journal of Neuroscience

Volumn 33, Issue 34, 2013, Pages 13784-13790

  Geuter, Stephan ^a   Büchel, Christian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; MALE; NOCICEPTION; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; TEMPERATURE; THERMAL STIMULATION; VISUAL ANALOG SCALE;

ADULT; CAPSAICIN; FEMALE; HUMANS; HYPERALGESIA; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; PAIN; PAIN MEASUREMENT; PAIN PERCEPTION; PAIN THRESHOLD; QUESTIONNAIRES; SPINAL CORD; TIME FACTORS; YOUNG ADULT;

EID: 84882589289     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2191-13.2013     Document Type: Article

References (52)

1. Amanzio M, Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19:484-494.
2. Atlas LY, Bolger N, Lindquist MA, Wager TD (2010) Brain mediators of predictive cue effects on perceived pain. J Neurosci 30:12964-12977.
3. Basbaum AI, Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309-338.
4. Benedetti F (2008) Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol 48:33-60.
5. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, Tracey I (2011) The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 3: 14-70.
6. Brooks JC, Beckmann CF, Miller KL, Wise RG, Porro CA, Tracey I, Jenkinson M (2008) Physiological noise modelling for spinal functional magnetic resonance imaging studies. Neuroimage 39:680-692.
7. Brooks JC, Kong Y, Lee MC, Warnaby CE, Wanigasekera V, Jenkinson M, Tracey I (2012) Stimulus site and modality dependence of functional activity within the human spinal cord. J Neurosci 32:6231-6239.
8. Buhle J, Wager TD (2010) Performance-dependent inhibition of pain by an executive working memory task. Pain 149:19-26.
9. Cahill CM, Stroman PW (2011) Mapping of neural activity produced by thermal pain in the healthy human spinal cord and brain stem: a functional magnetic resonance imaging study. Magn Reson Imaging 29:342-352.
10. Colloca L, Sigaudo M, Benedetti F (2008) The role of learning innocebo and placebo effects. Pain 136:211-218.
11. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F (2010) How the number of learning trials affects placebo and nocebo responses. Pain 151: 430-439.
12. Cooke FJ, Blamire AM, Manners DN, Styles P, Rajagopalan B (2004) Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord. Magn Reson Med 51:1122-1128.
13. Dworkin SF, Chen AC, LeResche L, Clark DW (1983) Cognitive reversal of expected nitrous oxide analgesia for acute pain. Anesth Analg 62:1073-1077.
14. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C (2009a) Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63:533-543.
15. Eippert F, Finsterbusch J, Bingel U, Büchel C (2009b) Direct evidence for spinal cord involvement in placebo analgesia. Science 326:404.
16. Enck P, Benedetti F, Schedlowski M (2008) New insights into the placebo and nocebo responses. Neuron 59:195-206.
17. Fields H (2004) State-dependent opioid control of pain. Nat Rev Neurosci 5:565-575.
18. Finsterbusch J, Eippert F, Büchel C (2012) Single, slice-specific z-shim gradient pulses improve T2*-weighted imaging of the spinal cord. Neuroim-age 59:2307-2315.
19. Finsterbusch J, Sprenger C, Büchel C (2013) Combined T2*-weighted measurements of the human brain and cervical spinal cord with a dynamic shim update. Neuroimage 79:153-161.
20. Franz VH, Loftus GR (2012) Standard errors and confidence intervals in within-subjects designs: generalizing Loftus and Masson (1994) and avoiding the biasesof alternative accounts. Psychon Bull Rev 19:395-404.
21. Gibbons RD, Hedeker DR, Davis JM (1993) Estimation of effect size from a series of experiments involving paired comparisons. J Educ Behav Stat 18:271-279.
22. Gläscher J (2009) Visualization of group inference data in functional neu-roimaging. Neuroinform 7:73-82.
23. Glover GH, Li TQ, Ress D (2000) Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magn Reson Med 44:162-167.
24. Goffaux P, Redmond WJ, Rainville P, Marchand S (2007) Descending an-algesia-when the spine echoes what the brain expects. Pain 130:137-143.
25. Kong J, Gollub RL, Polich G, Kirsch I, Laviolette P, Vangel M, Rosen B, Kaptchuk TJ (2008) A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci 28: 13354-13362.
26. Kong Y, Jenkinson M, Andersson J, Tracey I, Brooks JC (2012) Assessment of physiological noise modelling methods for functional imaging of the spinal cord. Neuroimage 60:1538-1549.
27. Kovelowski CJ, Ossipov MH, Sun H, Lai J, Malan TP, Porreca F (2000) Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat. Pain 87:265-273.
28. Koyama T, McHaffie JG, Laurienti PJ, Coghill RC (2005) The subjective experienceof pain: where expectations become reality. Proc Natl Acad Sci USA 102:12950-12955.
29. Levine JD, Gordon NC, Fields HL (1978) The mechanism of placebo analgesia. Lancet 312:654-657.
30. Light AR, Perl ER (1979) Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers. J Comp Neurol 186:133-150.
31. Loftus GR, Masson MEJ (1994) Using confidence intervals in within-subject designs. Psychon Bull Rev 1:476-490.
32. Lorenz J, Hauck M, Paur RC, Nakamura Y, Zimmermann R, Bromm B, Engel AK (2005) Cortical correlates of false expectations during pain intensity judgments-a possible manifestation of placebo/nocebo cognitions. Brain Behav Immun 19:283-295.
33. Marshall TM, Herman DS, Largent-Milnes TM, Badghisi H, Zuber K, Holt SC, Lai J, Porreca F, Vanderah TW (2012) Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cho-lecystokinin elicits release of prostaglandin-E2 in the spinal cord. Pain 153:86-94.
34. Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355-474.
35. Mogil JS, Sorge RE, LaCroix-Fralish ML, Smith SB, Fortin A, Sotocinal SG, Ritchie J, Austin JS, Schorscher-Petcu A, Melmed K, Czerminski J, Bit-tong RA, Mokris JB, Neubert JK, Campbell CM, Edwards RR, Campbell JN, Crawley JN, Lariviere WR, Wallace MR, et al (2011) Pain sensitivity and vasopressin analgesia are mediated by a gene-sex-environment interaction. Nat Neurosci 14:1569-1573.
36. Montgomery GH, Kirsch I (1996) Mechanisms of placebo pain reduction: an empirical investigation. Psychol Sci 7:174-176.
37. Neubert MJ, Kincaid W, Heinricher MM (2004) Nociceptive facilitating neuronsinthe rostral ventromedial medulla. Pain 110:158-165.
38. Petrovic P (2008) Placebo analgesia and nocebo hyperalgesia-two sides of the same coin? Pain 136:5-6.
39. Piché M, Cohen-Adad J, Nejad MK, Perlbarg V, Xie G, Beaudoin G, Benali H, Rainville P (2009) Characterization of cardiac-related noise in fMRI of the cervical spinal cord. Magn Reson Imaging 27:300-310.
40. Rodriguez-Raecke R, Doganci B, Breimhorst M, Stankewitz A, Büchel C, Birklein F, May A (2010) Insular cortex activity is associated with effects of negative expectation on nociceptive long-term habituation. J Neurosci 30:11363-11368.
41. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2008) Placebo and nocebo effects are defined by opposite opioid and dopami-nergic responses. Arch Gen Psychiatry 65:220-231.
42. Sotgiu ML, Brambilla M, Valente M, Biella GE (2004) Contralateral input modulates the excitability of dorsal horn neurons involved in noxious signal processes. Potential rolein neuronal sensitization. Somatosens Mot Res 21:211-215.
43. Sprenger C, Eippert F, Finsterbusch J, Bingel U, Rose M, Büchel C (2012) Attention modulates spinal cord responses to pain. Curr Biol 22:1019-1022.
44. Stroman PW, Nance PW, Ryner LN (1999) BOLD MRI of the human cervical spinal cord at 3 tesla. Magn Reson Med 42:571-576.
45. Summers PE, Ferraro D, Duzzi D, Lui F, Iannetti GD, Porro CA (2010) A quantitative comparison of BOLD fMRI responses to noxious and innocuous stimuli in the human spinal cord. Neuroimage 50:1408-1415.
46. Urban MO, Gebhart GF (1999) Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 96:7687-7692.
47. Valet M, Sprenger T, Boecker H, Willoch F, Rummeny E, Conrad B, Erhard P, Tolle TR (2004) Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain-an fMRI analysis. Pain 109:399-408.
48. Voudouris NJ, Peck CL, Coleman G (1989) Conditioned response models of placebo phenomena: further support. Pain 38:109-116.
49. Voudouris NJ, Peck CL, Coleman G (1990) The role of conditioning and verbal expectancy in the placebo response. Pain 43:121-128.
50. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD (2004) Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 303:1162-1167.
51. Wang X, Zhang J, Eberhart D, Urban R, Meda K, Solorzano C, Yamanaka H, Rice D, Basbaum AI (2013) Excitatory superficial dorsal horn interneu-rons are functionally heterogeneous and required for the full behavioral expression of pain and itch. Neuron 78:312-324.
52. Whalley B, Hyland ME, Kirsch I (2008) Consistency of the placebo effect. J Psychosom Res 64:537-541.